CompletedNot Applicable

Inflammation, Epigenetics in CHF Patients With AF

Italy164 participantsStarted 2020-01-01

Plain-language summary

the goal of this case-control cross-sectional study is assessing in a cohort of patients with CHF and permanent AF * The serum levels of some candidate cytokine variables and their relationship with some selected metabolic variables and some echocardiographic variables. * the expression degree of some selected miRNA with a pathogenetic relation to atrial fibrillation and the related cardiac remodelling. * to analyze the correlation between selected miRNA and the selected cytokines.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * ≥18 years * Left ventricular ejection fraction \>40% * New York Heart Association class II-IV symptoms * NT-proBNP ≥600 pg/mL, or ≥900 pg/mL if AF was present on baseline electrocardiography Exclusion Criteria \- Other AF subtypes (paroxysmal, persistent, long-standing persistent) At least one of the following criteria: * Acute heart failure * NYHA IV * NT-proBNP \>4000 pg/mL * Significant valvular disease * Mechanical prosthesis * Cardiovascular implantable devices * Active malignancy * Inflammatory or infectious diseases * Severe renal (eGFR \<30 mL/min/m²) or hepatic failure * Chronic steroid/anti-inflammatory therapy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

inflammation and structural cardiac remodelling

Timeframe: From January 2020 to May 2022

Trial details

NCT IDNCT07152301

SponsorUniversity of Palermo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-31

View on ClinicalTrials.gov More Congestive Heart Failure Chronic trials